Thermo: SDS Page price cuts in keeping with China's 5-year plan
Thermo Fisher Scientific has confirmed that the price cuts imposed by Chinese M&A authorities are part of the country’s efforts to become and biopharmaceutical hub.
Archives for February 6, 2014
AbbVie to open $320m Singapore facility with ADC capacity
AbbVie has invested $320m (€432m) into its first Asian manufacturing facility and says it will support an emerging antibody-drug conjugate (ADC) pipeline.